FrancophonIA/ELRC3.0 huggingface dataset:
English: Fungal infection, bacterial infection, pulmonary infection, nasopharyngitis, pharyngitis streptococcal, otitis media, sinusitis, tooth abscess, influenza, oral herpes, herpes simplex, urinary tract infection, vaginitis, gastroenteritis
Maltese: Infezzjoni tal-fungu, infezzjoni batterika, infezzjoni pulmonari, nażofarinġite, farinġite streptokokkali, otitis media, sinusite, tnawwir ta' snien, influwenza, herpes orali, herpes simplex, infezzjoni tal-passaġġ awrinarju, vaginite, gastroenterite
English: Hyperthyroidism, virilism
Maltese: Ipertajrojdiżmu, viriliżmu
English: Limited safety data (N = 25) are available in co-infected patients with CD4+ cell counts < 200/µL (see section 4.4).
Maltese: Hemm tagħrif limitat (N = 25) dwar is-sigurtà f'pazjenti li jkollhom infezzjoni fl-istess ħin b'għadd ta' ċelluli CD4+ < 200/µL (ara sezzjoni 4.4).
English: If an acute hypersensitivity reaction (e.g., urticaria, angioedema, bronchoconstriction, anaphylaxis) develops, Ribavirin Teva Pharma B.V. must be discontinued immediately and appropriate medical therapy instituted.
Maltese: Jekk tiżviluppa reazzjoni ta' sensittività eċċessiva akuta (eż. urtikarja, anġjodema, jidjiequ l-bronki, anafilassi), Ribavirin Teva Pharma B.V. għandu jitwaqqaf minnufih u tinbeda terapija medika xierqa.
English: Ribavirin Teva Pharma B.V. 400 mg film-coated tablets are light-pink to pink, (debossed with “R” on one side and “400” on the other).
Maltese: Ribavirin Teva Pharma B.V. 400 mg huma pilloli miksija b'rita ta' lewn roża ċar għal roża, (intaljati b' “R” fuq naħa waħda u “400” fuq in-naħa l-oħra).
English: Arthralgia, myalgia, musculoskeletal pain
Maltese: Artralġja, uġigħ fil-muskoli, uġigħ muskoluskeletriku
English: Ribavirin may be used in combination with interferon alfa-2b (see section 4.4).
Maltese: Ribavirin jista' jintuża flimkien ma' interferon alfa-2b (ara sezzjoni 4.4).
English: Adult patients with moderate renal impairment (creatinine clearance of 30-50 mL/minute) should be administered alternating daily doses of 200 mg and 400 mg.
Maltese: Pazjenti adulti b'indeboliment moderat tal-kliewi (tneħħija tal-kreatinina ta' 30-50 mL/minuta) għandhom jingħataw dożi jalternaw kuljum ta' 200 mg u 400 mg.
English: Haemolysis
Maltese: Ipotajrojdiżmu
English: The Kaplan-Meier estimate for continued sustained response over 5 years is 97 % (95 % CI: 95-99 %) for patients receiving nonpegylated interferon alfa-2b (with or without ribavirin), and is 99 % (95 % CI: 98-100 %) for patients receiving pegylated interferon alfa-2b (with or without ribavirin).
Maltese: L-istima Kaplan-Meier għal rispons sostnut fuq tul ta' 5 snin hija 97 % (95 % CI: 95-99 %) għal pazjenti li kienu qed jirċievu interferon alfa-2b mhux pegilat (bi jew mingħajr ribavirin), u hija 99 % (95 % CI: 98-100 %) għal pazjenti li kienu qed jirċievu interferon alfa-2b pegilat (bi jew mingħajr ribavirin).
English: 2 tablets in the morning and 2 tablets in the evening or 1 (400 mg) tablet in the morning and 1 (400 mg) tablet in the evening See adult dose
Maltese: 2 pilloli filgħodu u 2 pilloli filgħaxija jew pillola 1 (400 mg) filgħodu u pillola 1 (400 mg) filgħaxija
English: Female: amenorrhea, menorrhagia, menstrual disorder, dysmenorrhea, breast pain, ovarian disorder, vaginal disorder.
Maltese: Nisa: amenorrea, menorragja, disturbi menstruwali, dismenorrea, uġigħ fis-sider, disturb ovarjan, disturb vaġinali.
English: Pericardial effusion*, pericarditis*
Maltese: Attakki ta' puplesja (konvulsjoni)*, newropatija periferali*
English: 600 mg
Maltese: 200 mg kuljum
English: Light pink to pink, (debossed with “93” on one side and “7232” on the other).
Maltese: Roża ċara għal roża (intaljata b'“93” fuq naħa waħda u “7232” fuq naħa oħra).
English: Older people (≥ 65 years of age)
Maltese: Persuni akbar fl-età (≥ 65 sena)
English: No pharmacokinetic interactions were noted between ribavirin and peginterferon alfa-2b or interferon alfa-2b in a multiple-dose pharmacokinetic study.
Maltese: L-ebda interazzjonijiet farmakokinetiċi ma kienu nnotati bejn Ribavirin u peginterferon alfa-2b jew interferon alfa-2b fi studju farmakokinetiku b'dożi multipli.
English: Children and adolescents 3 to 16 years of age with compensated chronic hepatitis C and detectable HCV-RNA (assessed by a central laboratory using a research-based RT-PCR assay) were enrolled in two multicentre trials and received ribavirin 15 mg/kg per day plus interferon alfa-2b 3 MIU/m2 3
Maltese: Tfal u adoloxxenti minn 3 sa 16-il sena b'epatite Ċ kronika kumpensata u HCV-RNA li setgħu jitkejlu (imkejjel minn laboratorju ċentrali bl-użu ta' assaġġ permezz tal-RT-PCR li jintuża għar-riċerka) kienu arwolati f'żewġ provi multiċentrali u rċevew ribavirin 15 mg/kg kuljum flimkien ma' interferon alfa-2b 3 MIU/m
English: Discontinue ribavirin if:
Maltese: Waqqaf ribavirin jekk:
English: Conjunctival haemorrhage, eye pruritus, keratitis, vision blurred, photophobia
Maltese: Emorraġija konġuntivali, ħakk fl-għajnejn, keratite, vista mċajpra, fotofobija
English: Bacterial infection (including sepsis), fungal infection, influenza, respiratory tract infection, bronchitis, herpes simplex, sinusitis, otitis media, rhinitis, urinary tract infection
Maltese: Infezzjoni batterika (li tinkludi sepsis), infezzjoni tal-fungu, influwenza, infezzjoni flapparat respiratorju, bronkite, herpes simplex, sinusite, otitis media, rinite, infezzjoni filpassaġġ awrinarju
English: Pallor, flushing
Maltese: Sfurija, fwawar
English: - Genotoxicity: Ribavirin induces genotoxicity (see section 5.3).
Maltese: Ribavirin tikkaġuna l-ġenotossiċità (ara sezzjoni 5.3).
English: In clinical trials with ribavirin used in combination with peginterferon alfa-2b or interferon alfa-2b, the maximum overdose reported was a total dose of 10 g of ribavirin (50 x 200 mg capsules) and 39 MIU of interferon alfa-2b (13 subcutaneous injections of 3 MIU each) taken in one day by a patient in an attempt at suicide.
Maltese: Fi studji kliniċi b'ribavirin li intuża flimkien ma' peginterferon alfa-2b jew interferon alfa-2b, id-doża eċċessiva massima rrappurtata kienet doża totali ta' 10 g ta' ribavirin (50 kapsula x 200 mg) u 39 MIU ta' interferon alfa-2b (13 injezzjonijiet taħt il-ġilda ta' 3 MIU each) meħuda f'ġurnata waħda minn pazjent f'tentattiv ta' suwiċidju.
English: Upon discontinuation of dosing the half-life was approximately 298 hours, which probably reflects slow elimination from non-plasma compartments.
Maltese: Wara l-waqfien tad-dożaġġ, il-half life kienet ta' madwar 298 siegħa, li probabilment tirrifletti l-eliminazzjoni bil-mod mill-kompartament mhux tal-plażma.
English: • have problems with your kidneys.
Maltese: • għandha problemi fil-kliewi
English: Overall Responsea (n=118) Genotype 1 (n=92) Genotype 2/3/4 (n=26)
Maltese: Ġenotip 2/3/4 (n=26)
English: This decline was significant among responders (-0.3 for Metavir and -1.2 for Ishak) and stable (-0.1 for Metavir and -0.2 for Ishak) among non-responders.
Maltese: Dan it-tnaqqis kien sinifikanti fost dawk li wrew rispons (-0.3 għal Metavir u -1.2 għal Ishak) u stabbli (-0.1 għal Metavir u -0.2 for Ishak) fost dawk li ma kellhomx rispons.
English: This should be discussed with your doctor (see “Do not take Ribavirin Teva Pharma B.V.”).
Maltese: Dan għandu jiġi diskuss mat-tabib tiegħek (ara “Tiħux Ribavirin Teva Pharma B.V.”).
English: Pure red cell aplasia, idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura
Maltese: Aplasja pura taċ-ċellula ħamra, purpura tromboċitopenika idjopatika, purpura tromboċitopenika trombotika
English: Mitochondrial toxicity and lactic acidosis: Caution should be taken in HIV-positive subjects coinfected with HCV who receive nucleoside reverse transcriptase inhibitor (NRTI) treatment (especially ddI and d4T) and associated interferon alfa-2b/ribavirin treatment.
Maltese: Kawtela għandha tittieħed f'individwi li rriżultaw pożittivi għal HIV u li huma ko-infettati b'HCV li qed jirċievu trattament bl-impedituri ta' nucleoside reverse transcriptase (NRTI) (l-aktar ddI u d4T) u t-trattament assoċjat b'interferon alfa-2b/ribavirin.
English: Although, the majority of them could be managed by dose reduction, close monitoring of haematological parameters should be undertaken in this population of patients (see section 4.2 and below “Laboratory tests” and section 4.8).
Maltese: Għalkemm, il-biċċa tagħhom jistgħu jkunu ġestiti bi tnaqqis fid-doża, monitoraġġ mill-qrib ta' parametri ematoloġiċi għandu jsir f'din il-popolazzjoni ta' pazjenti (ara sezzjoni 4.2 u hawn isfel “Testijiet tallaboratorju” u sezzjoni 4.8).
English: Treatment with ribavirin in combination with peginterferon alfa-2b was associated with decreases in absolute CD4+ cell counts within the first 4 weeks without a reduction in CD4+ cell percentage.
Maltese: Trattament b'ribavirin f'kombinazzjoni ma' peginterferon alfa-2b kien assoċjat ma' tnaqqis fl-għadd assolut ta' ċelluli CD4+ fl-4 ġimgħat mingħajr tnaqqis fil-perċentwali ċellulari ta' CD4+.
English: Metabolism and nutrition disorders
Maltese: Disturbi fil-metaboliżmu u n-nutrizzjon
English: Two trials examined the use of ribavirin and interferon alfa-2b combination treatment in relapse patients (C95-144 and I95-145); 345 chronic hepatitis patients who had relapsed after previous interferon treatment were treated for six months with a six month follow-up.
Maltese: Żewġ studji li eżaminaw l-użu kkombinat ta' ribavirin u interferon alfa-2b f'pazjenti li jirkadu (C95-144 u I95-145); 345 pazjent b'epatite kronika li kienu diġà rkadew b'trattament ta' interferon li ngħata qabel, kienu ttrattati għal sitt xhur ta' follow-up.
English: Each tablet contains 400 mg of ribavirin
Maltese: Kull pillola fiha 400 mg of ribavirin
English: For paediatric patients (children and adolescents) weighing less than 47 kg a solution formulation is available.
Maltese: Għal pazjenti pedjatriċi (tfal u adoloxxenti) li jiżnu inqas minn 47 kg hemm soluzzjoni hija disponibbli.
English: Tabulated list of adverse reactions in paediatric population Reported adverse reactions listed in Table 6 are based on experience from the two multicentre children and adolescents clinical trials using ribavirin with interferon alfa-2b or peginterferon alfa-2b.
Maltese: Lista ta' reazzjonijiet avversi miġbura f'tabella fil-popolazzjoni pedjatrika Reazzjonijiet avversi rrappurtati elenkati f'Tabella 6 huma bażati fuq l-esperjenza minn żewġ provi kliniċi, multiċentrali, fi tfal u adoloxxenti li għalihom intużaw ribavirin ma' interferon alfa-2b jew peginterferon alfa-2b.
English: Other medicines and Ribavirin Teva Pharma B.V.
Maltese: Mediċini oħra u Ribavirin Teva Pharma B.V.
English: Dyspnoea, tachypnea, epistaxis, coughing, nasal congestion, nasal irritation, rhinorrhoea, sneezing, pharyngolaryngeal pain
Maltese: Dispnea, takipnea, epistassi, sogħla, konġestjoni nasali, irritazzjoni nasali, rinorrea, għatis, uġigħ faringolarinġeali
English: The following side effects have been reported with the combination of ribavirin and an alpha interferon product in adults:
Maltese: L-effetti l-oħra li ġejjin ġew rapportati mal-kombinazzjoni ta' ribavirin u prodott ta' alpha interferon f'adulti:
English: However, in a population pharmacokinetic study, age was not a key factor in the kinetics of ribavirin; renal function is the determining factor.
Maltese: Madankollu fi studju farmakokinetiku dwar il-popolazzjoni, l-età ma kinetx fattur importanti fil-kinetika ta' ribavirin; ilfunzjoni renali hija l-fattur determinanti.
English: Suicide attempts, panic attack, hallucination
Maltese: Tenattivi ta' suwiċidju, attakki ta' paniku, alluċinazzjoni
English: Hepatic function
Maltese: Funzjoni epatika
English: Ribavirin in combination with peginterferon alfa-2b
Maltese: Ribavirin f'kombinazzjoni ma' peginterferon alfa-2b
English: Pancytopenia and bone marrow suppression have been reported in the literature to occur within 3 to 7 weeks after the administration of a peginterferon and ribavirin concomitantly with azathioprine.
Maltese: Fil-letteratura, panċitopenija u soppressjoni tal-mudullun kienu rrapportati li jseħħu fi żmien 3 sa 7 ġimgħat wara l-għoti ta' peginterferon u ribavirin flimkien ma' azathioprine.
English: Patients whose dose of Ribavirin Teva Pharma B.V. is reduced to 600 mg daily receive one 200 mg tablet in the morning and two 200 mg tablets in the evening.
Maltese: Pazjenti li jkollhom id-doża ta' Ribavirin Teva Pharma B.V. tagħhom imnaqqsa għal 600 mg kuljum jirċievu pillola waħda ta' 200 mg filgħodu u żewġ pilloli ta' 200 mg filgħaxija.
English: In subjects with creatinine clearance between 30 and 50 mL/min, AUCtf was twofold greater compared with control subjects.
Maltese: F'individwi bi tneħħija tal-kreatinina bejn 30 u 50 mL/min, l-AUCtf kienet darbtejn aktar meta mqabbla mal-individwi bħala kontroll.
English: Each tablet contains 200 mg of ribavirin
Maltese: Kull pillola fiha 200 mg of ribavirin
English: Micturition frequency, polyuria, urine abnormality
Maltese: Frekwenza biex tgħaddi l-awrina, poliurja, anormalità flurina
English: In general, the adverse event profile in the limited children and adolescent population studied was similar to that observed in adults, although there is a paediatric-specific concern regarding growth inhibition, as decrease in height percentile (mean percentile decrease of growth velocity of 9 percentile) and weight percentile (mean percentile decrease of 13 percentile) were observed during treatment.
Maltese: B'mod ġenerali, il-profil ta' effetti avversi fil-popolazzjoni pedjatrika limitata ta' tfal u adoloxxenti li kienet studjata kien simili għal dak osservat fl-adulti, għalkemm l-impediment ta' żvilupp huwa ta' tħassib speċifiku għall-popolazzjoni pedjatrika, peress li tnaqqis perċentili fit-tul (tnaqqis perċentwali medju tar-rata tat-tkabbir ta' 9 perċentili) u fil-perċentil fil-piż (tnaqqis perċentili medju ta' 13-il perċentil) kienu osservati waqt it-trattament.
English: Light pink to pink, (debossed with “R” on one side and “400” on the other).
Maltese: Roża ċara għal roża (intaljata b'“R” fuq naħa waħda u “400” fuq naħa oħra).
English: Genotype
Maltese: Epatomegali
English: Ear and labyrinth disorders
Maltese: Valuri tal-laboratorju
English: For patients receiving a 800 mg (< 65 kg) - 1,000 mg (65-80 kg) - 1,200 mg (81-105 kg) or 1,400 mg (> 105 kg) dose, 1st dose reduction of Ribavirin Teva Pharma B.V. is by 200 mg/day (except in patients receiving the 1,400 mg, dose reduction should be by 400 mg/day).
Maltese: Għal pazjenti li jkunu qed jirċievu doża ta' 800 mg (< 65 kg)-1,000 mg (65-80 kg)-1,200 mg (81-105 kg) jew 1,400 mg (> 105 kg), l-1el tnaqqis fid-doża ta' Ribavirin Teva Pharma B.V. ikun ta'
English: Each Ribavirin Teva Pharma B.V. tablet contains 200 mg of ribavirin For the full list of excipients, see section 6.1.
Maltese: Kull pillola ta' Ribavirin Teva Pharma B.V fiha 200 mg ta' ribavirin Għal-lista kompluta ta' eċċipjenti, ara sezzjoni 6.1.
English: Adult patients: Ribavirin Teva Pharma B.V. is indicated, in combination with interferon alfa-2b, for the treatment of adult patients with all types of chronic hepatitis C except genotype 1, not previously treated, without liver decompensation, with elevated alanine aminotransferase (ALT), who are positive for hepatitis C viral ribonucleic acid HCV-RNA (see section 4.4).
Maltese: Ribavirin Teva Pharma B.V. huwa indikat għall-użu, flimkien ma' interferon alfa-2b, għal trattament f'pazjenti adulti b'kull tip ta' epatite Ċ kronika, ħlief ġenotip 1, li ma kienux ikkurati qabel, mingħajr fwied mhux kompensat, b'alanine aminotransferase (ALT) għoli, li huma pożittivi għal ribonucleic acid virali ta' epatite Ċ, HCV-RNA fis-serum (ara sezzjoni 4.4).
English: Ribavirin, by having an inhibitory effect on inosine monophosphate dehydrogenase, may interfere with azathioprine metabolism possibly leading to an accumulation of 6-methylthioinosine monophosphate (6-MTIMP), which has been associated with myelotoxicity in patients treated with azathioprine.
Maltese: Ribavirin, minħabba li jista' jkollu effett inibitorju fuq inosine monophosphate dehydrogenase, jista' jinterferixxi mal-metaboliżmu ta' azathioprine billi possibilment iwassal għal akkumulazzjoni ta' 6-methyl monophosphate (6-MTIMP), li hu assoċjat ma' mijelotossiċità f'pazjenti ikkurati b'azathioprine.L-użu ta' pegylated alpha interferons u ribavirin flimkien ma' azathioprine għandu jiġi evitat.
English: Table 6 Adverse reactions very commonly, commonly and uncommonly reported during clinical trials in children and adolescents with ribavirin in combination with interferon alfa-2b or peginterferon alfa-2b
Maltese: Tabella 6 Effetti avversi komuni rapportati b'mod komuni, komuni u mhux komuni waqt il-provi kliniċi fi tfal u adoloxxenti b'ribavirin f'kombinazzjoni ma' interferon alfa-2b jew peginterferon alfa-2b
English: The bioavailability of ribavirin 600 mg was decreased by co-administration with an antacid containing magnesium aluminium and simethicone; AUCtf decreased 14 %.
Maltese: Il-bijodisponibilità ta' ribavirin 600 mg kienet imnaqqsa meta ngħata flimkien ma' antaċidu li kien fih manjesju aluminju u simethicone; AUCtf tnaqqas b'14 %.
English: a: p value based on Cochran-Mantel Haenszel Chi square test. b: p value based on chi-square test. c: subjects < 75 kg received 100 µg/week peginterferon alfa-2b and subjects ≥ 75 kg received 150 µg/week peginterferon alfa-2b .
Maltese: b: valur p ibbażat fuq it-test chi-square. c: individwi < 75 kg ħadu 100 µg/ġimgħa peginterferon alfa-2b u individwi ≥ 75 kg irċevew 150 µg/ġimgħa peginterferon alfa-2b. d: dożaġġ ta' Ribavirin kien 800 mg għal pazjenti < 60 kg, 1,000 mg għal pazjenti 60-75 kg, u 1,200 mg għal pazjenti > 75 kg.
English: Each Ribavirin Teva Pharma B.V. tablet contains 400 mg of ribavirin For the full list of excipients, see section 6.1.
Maltese: Kull pillola ta' Ribavirin Teva Pharma B.V fiha 400 mg ta' ribavirin Għal-lista kompluta ta' eċċipjenti, ara sezzjoni 6.1.
English: Neuropathy, peripheral neuropathy
Maltese: Newtropenja, newropatija periferika
English: Mean (% CV) multiple-dose pharmacokinetic parameters for interferon alfa-2b and ribavirin when administered to paediatric patients with chronic hepatitis C
Maltese: Medja (% CV) ta' parametri farmakokinetiċi b'ħafna dożi għal for interferon alfa-2b u ribavirin meta jingħataw lil pazjenti pedjatriċi b'epatite Ċ kronika
English: Viral infection, pharyngitis
Maltese: Infezzjoni virali, farinġite
English: * Since ribavirin has always been prescribed with an alpha interferon product, and the listed adverse drug reactions included reflecting post-marketing experience do not allow precise quantification of frequency, the frequency reported above is from clinical trials using ribavirin in combination with interferon alfa-2b (pegylated or nonpegylated).
Maltese: *Peress li ribavirin dejjem ġie preskritt dejjem ma' prodott ta' alfa interferon u l-lista elenkata ta' reazzjonijiet avversi kienet tinkludi l-esperjenza ta' wara t-tqegħid fis-suq ma tippermettix kwantifikazzjoni preċiża tal-frekwenzi, il-frekwenza rapportata haw fuq hi mill-provi kliniċi meta ribavirin intuża flimkien ma' interferon alfa-2b (pergilat jew mhux pergilat)
English: The combination of Ribavirin Teva Pharma B.V. with interferon alfa-2b is used to treat patients 3 years of age and older who have chronic hepatitis C (HCV) infection.
Maltese: Il-kombinazzjoni ta' Ribavirin Teva Pharma B.V. ma' interferon alfa-2b tintuża biex jiġu kkurati pazjenti ta' mhux inqas minn 3 snin li għandhom epatite Ċ kronika (HCV).
English: Dyspnoea, coughing
Maltese: Dispnea, sogħla
English: • Ribavirin (1,000/1,200 mg/day) + peginterferon alfa-2b (1.5 micrograms/kg/week for one month followed by 0.5 microgram/kg/week for 11 months) (n = 514).
Maltese: • Ribavirin (1,000/1, mg/jum) + peginterferon alfa-2b (1.5 mikrogrammi/kg/ġimgħa għal xahar segwita b'0.5 mikrogrammi/kg/ġimgħa għal 11-il xahar) (n = 514).
English: Conflicting findings are reported in literature on co-administration between abacavir and ribavirin.
Maltese: Riżultati konfliġġenti huma rrapportati fil-letteratura medika dwar l-għoti fl-istess żmien bejn abacavir u ribavirin.
English: A decrease in haemoglobin levels to < 10 g/dL was observed in up to 14 % of adult patients and 7 % of children and adolescents treated with ribavirin in combination with peginterferon alfa-2b or interferon alfa-2b in clinical trials.
Maltese: Tnaqqis fil-livelli ta' emoglobina għal < 10 g/dL kien osservat f'sa 14 % ta' pazjenti adulti u 7 % ta' tfal u adoloxxenti ttrattati b'ribavirin flimkien ma' peginterferon alfa-2b (adulti biss) jew interferon alfa-2b (adulti u tfal jew adoloxxenti) fi provi kliniċi.
English: Cardiomyopathy*, arrhythmia*
Maltese: Kardjomijopatija*, arrithmija*
English: In HCV/HIV co-infected patients receiving cART, the following other side effects have occurred with the combination of ribavirin and peginterferon alfa-2b (not listed above in adults side effects): appetite decreased, back pain, CD4 lymphocytes decreased, defective metabolism of fat, hepatitis, limb pain, oral candidiasis (oral thrush), various laboratory blood values abnormalities.
Maltese: F'pazjenti koinfettati b'HCV/HIV li qed jirċievu cART, effetti kollaterali oħra li ġejjin seħħew bil-kombinazzjoni ta' ribavirin u peginterferon alfa-2b (mhux elenkat hawn fuq fl-effetti sekondarji tal-adulti): - tnaqqis fl-aptit - uġigħ fid-dahar - tnaqqis fl-għadd ta' limfoċiti ta' CD4 - metaboliżmu difettuż tax-xaħam, - epatite, - uġigħ fid-dirgħajn/riġlejn - kandidijasi orali - anormalitajiet f'diversi riżultati tad-demm tal-laboratorju
English: p valueb
Maltese: Valur pb
English: Ribavirin Dose (daily)
Maltese: Doża ta' ribavirin (kuljum)
English: Both female and male patients must take special precautions in their sexual activity if there is any possibility for pregnancy to occur:
Maltese: Kemm pazjenti nisa u anke rġiel għandhom jieħdu prekawzjonijiet speċjali fl-attività sesswali tagħhom jekk hemm il-possibilità ta' tqala:
English: Results of in vitro studies using both human and rat liver microsome preparations indicated no cytochrome P450 enzyme mediated metabolism of ribavirin.
Maltese: Ir-riżultati minn studji in vitro li fihom intużaw preparazzjonijiet ta' mikrożomi tal-fwied kemm tal-bniedem kif ukoll tal-firien ma indikaw l-ebda metaboliżmu ta' ribavirin medjat mill-enżima ta' cytochrome P450.
English: Ribavirin in combination with interferon alfa-2b
Maltese: Ribavirin f'kombinazzjoni ma' interferon alfa-2b
English: HCV/HIV Co-infection
Maltese: Infezzjoni b'HCV/HIV fl-istess ħin
English: Number of 200 mg tablets*
Maltese: Numru ta' pilloli ta' 200 mg
English: In a clinical trial with 107 children and adolescent patients (3 to 17 years of age) treated with combination therapy of peginterferon alfa-2b and ribavirin, dose modifications were required in 25 % of patients, most commonly for anaemia, neutropenia and weight loss.
Maltese: Fi prova klinika b'107 pazjenti tfal u adoloxxenti (minn 3 snin sa 17-il sena) ittrattati b'terapija ta' kombinazzjoni ta' peginterferon alfa-2b u ribavirin, modifikazzjonijiet tad-doża kienu meħtieġa f'25 % tal-pazjenti, bl-aktar komuni ikunu għal anemija, newtropenija u telf fil-piż.
English: There is no evidence that ribavirin interacts with non-nucleoside reverse transcriptase inhibitors or protease inhibitors.
Maltese: M'hemm l-ebda evidenza li ribavirin jagħmel xi interazzjonijiet mal-impedituri ta' reverse transcriptase mhux nucleosides jew impedituri ta' protease.
English: Table 4 Dosage Modification for Renal Impairment in Adult Patients
Maltese: Tabella 4 Bidla fid-Dożaġġ għal Indeboliment tal-Kliewi f'Pazjenti Adulti
English: Most of the changes in laboratory values in the ribavirin/peginterferon alfa-2b clinical trial were mild or moderate.
Maltese: Ħafna mill-bidlet fil-valuri tal-laboratorju fil-prova klinika ta' ribavirin/peginterferon alfa-2b kienu ħfief jew moderati.
English: Anti-thyroid antibody positive
Maltese: Antikorp tal-antitirojdi pożittiv